PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board.
Hood has helped found several research and commercial enterprises, including Applied Biosystems (now part of Life Technologies), Amgen, and the Institute for System Biology, where he currently holds the position of president. He has won several awards including the 2003 AMP award for excellence in molecular diagnostics; the Academy of Engineering's Russ Prize; the Lasker Award; and the Kyoto Prize. He has more than 700 peer-reviewed articles and is a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
TrovaGene this week announced that it has named Antonius Schuh as CEO.
Schuh previously served as chairman and CEO of Sorrento Therapeutics, which merged in 2009 with a public company supported by Phillip Frost and the Frost Group. He also has served as founding CEO of AviaraDx (now operating as BioTheranostics under parent company BioMérieux). Prior to this he served as CEO of Arcturus; and president and CEO of Sequenom. He holds a PhD in medicinal chemistry from the University of Bonn.
PositiveID has appointed William Caragol as chairman of the board.
Caragol has been CEO since August 2011, president since 2007, and a member of the board since November 2009.
BioNano Genomics has hired Garth Monroe as CFO, the company said this week.
Prior to joining BioNano Genomics, Monroe was CFO of medical device firm Epocal (now part of Alere). He previously served as a station manager for JetBlue and financial analyst at United Technologies.